Routine Use of Swallowing Outcome Measures Following Head and Neck Cancer in a Multidisciplinary Clinic Setting
- PMID: 33968218
- PMCID: PMC8096508
- DOI: 10.1055/s-0040-1708896
Routine Use of Swallowing Outcome Measures Following Head and Neck Cancer in a Multidisciplinary Clinic Setting
Abstract
Introduction Chemoradiotherapy treatment for head and neck cancer (HNC) can have a major impact on swallowing function and health-related quality of life. The use of outcome measures in early detection of patients with swallowing problems provides the opportunity for targeting speech and language therapy (SLT) interventions to aid adaption and promote better clinical outcomes. Objective The purpose of the present study was to assess relationships between four outcomes measures over time, in a cohort of HNC patients, treated by (chemo-)radiotherapy. Methods Data were collected at 3 months and 12 months, on 49 consecutive patients with primary squamous cell cancer of the oropharynx, nasopharynx or hypopharynx stage T1-4, N0-2b, M0 disease. Results Out of 49 eligible patients, 45 completed assessment at 3 months and 20 at 12 months. The 3-month outcomes gave a strong indication of performance at 1 year. There were several strong correlations found between measures. The strongest was between the 3-month Performance Status Scale for Head and Neck Cancer (PSSHN) and the 12-month PSSHN (rs = 0.761, n = 17), the 12-month PSSHN and the 12-month Functional Oral Intake Scale (FOIS) (rs = 0.823, n = 20), and the 12-month University of Washington Head and Neck Quality of Life (UWQoL) swallow and the 12-month Water Swallow Test (WST) capacity (rs = 0.759, n = 17). Conclusion The UW-QoL swallow item and WST are easy to incorporate into routine care and should be used as part of a standard assessment of swallow outcome. These measures can serve to help screen patients for dysfunction and focus allocation of resources for those who would benefit from more comprehensive assessment and intervention by SLT.
Keywords: cancer; dysphagia; head and neck cancer; outcomes; quality of life; swallowing.
Fundação Otorrinolaringologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).
Conflict of interest statement
Conflict of Interests The authors have no conflict of interests to declare.
Figures
Similar articles
-
Global assessment of swallow function (GASF) following VMAT radiotherapy for head and neck squamous cell carcinoma.Tech Innov Patient Support Radiat Oncol. 2024 Aug 30;32:100272. doi: 10.1016/j.tipsro.2024.100272. eCollection 2024 Dec. Tech Innov Patient Support Radiat Oncol. 2024. PMID: 39346655 Free PMC article.
-
Evaluation of the limitations of using the University of Washington Quality of Life swallowing domain alone to screen patients in the routine clinical setting.Br J Oral Maxillofac Surg. 2013 Oct;51(7):e148-54. doi: 10.1016/j.bjoms.2012.05.009. Epub 2012 Jun 19. Br J Oral Maxillofac Surg. 2013. PMID: 22721809
-
Prevalence of swallowing and speech problems in daily life after chemoradiation for head and neck cancer based on cut-off scores of the patient-reported outcome measures SWAL-QOL and SHI.Eur Arch Otorhinolaryngol. 2016 Jul;273(7):1849-55. doi: 10.1007/s00405-015-3680-z. Epub 2015 Jun 14. Eur Arch Otorhinolaryngol. 2016. PMID: 26071622 Free PMC article.
-
Dysphagia Treatment for Patients With Head and Neck Cancer Undergoing Radiation Therapy: A Meta-analysis Review.Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):421-444. doi: 10.1016/j.ijrobp.2018.01.097. Epub 2018 Feb 6. Int J Radiat Oncol Biol Phys. 2018. PMID: 29726363
-
Addressing patients' concerns in speech and language therapy consultations following the diagnosis and treatment of head and neck cancer.Curr Opin Otolaryngol Head Neck Surg. 2023 Jun 1;31(3):159-164. doi: 10.1097/MOO.0000000000000881. Epub 2023 Mar 2. Curr Opin Otolaryngol Head Neck Surg. 2023. PMID: 36912235 Review.
Cited by
-
Global assessment of swallow function (GASF) following VMAT radiotherapy for head and neck squamous cell carcinoma.Tech Innov Patient Support Radiat Oncol. 2024 Aug 30;32:100272. doi: 10.1016/j.tipsro.2024.100272. eCollection 2024 Dec. Tech Innov Patient Support Radiat Oncol. 2024. PMID: 39346655 Free PMC article.
References
-
- Roe J WG.Swallowing following Intensity Modulated Radiotherapy for Head and Neck Cancer: Functional and Quality of Life Outcomes 2013. Ph.D.,Institute of Cancer Research, University of London
-
- Wilson J A, Carding P N, Patterson J M. Dysphagia after nonsurgical head and neck cancer treatment: patients' perspectives. Otolaryngol Head Neck Surg. 2011;145(05):767–771. - PubMed
-
- Kanatas A, Ghazali N, Lowe D, Udberg M, Heseltine J, O'Mahony E, Rogers S N. Issues patients would like to discuss at their review consultation: variation by early and late stage oral, oropharyngeal and laryngeal subsites. Eur Arch Otorhinolaryngol. 2013;270(03):1067–1074. doi: 10.1007/s00405-012-2092-6. - DOI - PubMed
-
- http://www.handle-on-qol.com. Last accessed May 2019
LinkOut - more resources
Full Text Sources
Research Materials